Nova Patents
AT448244T

Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung

Abstract

The present invention is the use of polyepitopic fragments of a protein determined object for the preparation of medicaments for the prevention or treatment of pathologies in which said protein is recognized by the cellular immune system, said polyepitopic fragments being chosen from those HIV Nef protein. The invention also relates to polyepitopic protein fragments of the Nef protein of HIV, their process of preparation, and their uses, particularly in the field of vaccination.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

28 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
9907012FranceA
0001514FranceW

Members28

Family members, oldest first
DocumentOfficeKind
FR2794370A1FranceA1
CA2375602A1CanadaA1
CA2375627A1CanadaA1
WO0075181A1World Intellectual Property Organization (WIPO)A1
WO0075336A2World Intellectual Property Organization (WIPO)A2
AU5229400AAustraliaA
AU5411000AAustraliaA
WO0075336A3World Intellectual Property Organization (WIPO)A3
EP1181314A1European Patent Office (EPO)A1
EP1183368A2European Patent Office (EPO)A2
FR2794370B1FranceB1
US6783763B1United States of AmericaB1
US2005033025A1United States of AmericaA1
US7288258B2United States of AmericaB2
US2008248044A1United States of AmericaA1
EP1181314B1European Patent Office (EPO)B1
AT448244TThis recordAustriaT
ATE448244T1AustriaT1
DE60043299D1GermanyD1
EP1181314B8European Patent Office (EPO)B8
EP2267132A2European Patent Office (EPO)A2
EP2267132A3European Patent Office (EPO)A3
EP1183368B1European Patent Office (EPO)B1
AT554172TAustriaT
ATE554172T1AustriaT1
ES2386803T3SpainT3
EP2267132B1European Patent Office (EPO)B1
ES2509901T3SpainT3